John Libbey Eurotext

Magnesium Research

MENU

The relationship between venous insufficiency and serum magnesium level Article à paraître

  • [1.] White JV, Ryjewski C. Chronic venous insufficiency. Perspect Vasc Surg Endovasc Ther 2005 ; 17 : 319-27.
  • [2.] Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation 2014 ; 130 : 333-46.
  • [3.] Yılmaz S. Alt Ekstremite Venöz Sistem Anatomisi ve Ultrasonografi İncelemesi. 27. Ulusal Radyoloji Kongresi Kurs Kitabı 2006 ; 94-100.
  • [4.] Scott TE, LaMorte WW, Gorin DR, Menzoian JO. Risk factors for chronic venous insufficiency: a dual case-control study. J Vasc Surg 1995 ; 22 : 622-8.
  • [5.] Youn YJ, Lee J. Chronic venous insufficiency and varicose veins of the lower extremities. Korean J Intern Med 2019 ; 34 : 269-83.
  • [6.] Sansilvestri-Morel P, Nonotte I, Fournet-Bourguignon MP, et al. Abnormal deposition of extracellular matrix proteins by cultured smooth muscle cells from human varicose veins. J Vasc Res 1998 ; 35 : 115-23.
  • [7.] Altura BM, Zhang A, Altura BT. Magnesium, hypertensive vascular diseases, atherogenesis, subcellüler compartmentation of Ca and Mg and vascular contractility, Miner Electrolyte Metab 1993 ; 19 : 323-36.
  • [8.] Maier JA, Castiglioni S, Locatelli L, et al. Magnesium and inflammation: advances and perspectives. Semin Cell Dev Biol 2021 ; 115 : 37-44.
  • [9.] Evangelopoulos AA, Vallianou NG, Panagiotakos DB, et al. An inverse relationship between cumulating components of the metabolic syndrome and serum magnesium levels. Nutr Res 2008 ; 28 : 659-63.
  • [10.] Gloviczki P, Gloviczki ML. Guidelines for the management of varicose veins. Phlebology 2012 ; 27 : 2-9.
  • [11.] Depopas E, Brown M. Varicose veins and lower extremity venous insufficiency. Semin Intervent Radiol 2018 ; 35 : 56-61.
  • [12.] Chiesa R, Marone E, Limoni C, Volonté M, Schaefer E, Petrini O. Chronic venous insufficiency in Italy: the 24-cities cohort study. Eur J Vasc Endovasc Surg 2005 ; 30 : 422-9.
  • [13.] Buján J, Jurado F, Gimeno MJ, et al. Changes in metalloproteinase (MMP-1, MMP-2) expression in the proximal region of the varicose saphenous vein in young subjects. Phlebology 2000 ; 15 : 64-70.
  • [14.] Castro-Ferreira R, Cardoso R, Leite-Moreira A, et al. The role of endothelial dysfunction and inflammation in chronic venous disease. Ann Vasc Surg 2018 ; 46 : 380-93.
  • [15.] Sansilvestri-Morel P, Rupin A, Badier-Commander C, et al. Imbalance in the synthesis of collagen type I and collagen type III in smooth muscle cells derived from human varicose veins. J Vasc Res 2001 ; 38 : 560-8.
  • [16.] Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary hearth disease in the MRFIT nested case-control study. Am J Epidemiol 1996 ; 144 : 537-47.
  • [17.] Tataru MC, Heinrich J, Junker R, et al. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. Eur Heart J 2000 ; 21 : 1000-8.
  • [18.] Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000 ; 102 : 2165-8.
  • [19.] Goh SL, De Silva RP, Dhital K, Gett RM. Is low serum albumin associated with postoperative complications in patients undergoing oesophagectomy for oesophageal malignancies? Interact Cardiovasc Thorac Surg 2015 ; 20 : 107-13.
  • [20.] Uluöz HO, Sebe A, Ay MO, et al. The relationship between inflammatory reagents and mortality in patients over the age of 55 hospitalised in the internal medicine intensive care unit from the emergency service. JAEM 2013 ; 12 : 13-8.
  • [21.] Leite HP, Fisberg M, de Carvalho WB, de Camargo Carvalho AC. Serum albumin and clinical outcome in pediatric cardiac surgery. Nutrition 2005 ; 21 : 553-8.
  • [22.] Çağdaş M, Rencüzoğullari İ, Karakoyun S, et al. Assessment of relationship between c-reactive protein to albumin ratio and coronary artery disease severity in patients with acute coronary syndrome. Angiology 2019 ; 70 : 361-8.
  • [23.] Ming L, Jiang Z, Ma J, Wang Q, Wu F, Ping J. Platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte ratio, and platelet indices in patients with acute deep vein thrombosis. Vasa 2018 ; 47 : 143-7.
  • [24.] Chen K, Zhan MX, Hu BS, et al. Combination of the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio as a useful predictor for recurrence following radiofrequency ablation of hepatocellular carcinoma. Oncol Lett 2018 ; 15 : 315-23.
  • [25.] Azab B, Shah N, Akerman M, McGinn JT Jr. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-STelevation myocardial infarction. J Thromb Thrombolysis 2012 ; 34 : 326-34.
  • [26.] Buyukkaya E, Karakas MF, Karakas E, et al. Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome. Clin Appl Thromb Hemost 2014 ; 20 : 159-63.
  • [27.] Turkmen K, Erdur FM, Ozcicek F, et al. Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int 2013 ; 17 : 391-6.
  • [28.] Oylumlu M, Yıldız A, Oylumlu M, et al. Platelet-to-lymphocyte ratio is a predictor of in-hospital mortality patients with acute coronary syndrome. Anatol J Cardiol 2015 ; 15 : 277-83.
  • [29.] Grudzińska E, Czuba ZP. Immunological aspects of chronic venous disease pathogenesis. Cent Eur J Immunol 2014 ; 39 : 525-31.
  • [30.] Budak AB, Günertem OE, Tümer NB, et al. Prognostic value of neutrophil-to-lymphocyte ratio in patients undergoing endovenous ablation therapy for venous insufficiency. Damar Cerrahi Dergisi 2017 ; 26 : 98-103.
  • [31.] Kalay N, Dogdu O, Koc F, et al. Hematologic parameters and angiographic progression of coronary atherosclerosis. Angiology 2012 ; 63 : 213-7.
  • [32.] Akpek M, Kaya MG, Lam YY, et al. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 2012 ; 110 : 621-7.
  • [33.] Engin M, Goncu MT. The role of plateletcrit and neutrophil lymphocyte ratio in showing the clinical severity of the disease in patients with chronic venous insufficiency. Ann Med Res 2020 ; 27 : 1385-90.
  • [34.] Canpolat U, Cetin EH, Cetin S, et al. Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation. Clin Appl Thromb Hemost 2016 ; 22 : 476-82.
  • [35.] Kanbay M, Solak Y, Unal HU, et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol 2014 ; 46 : 1619-25.
  • [36.] Alsancak Y, Ali S, Sivri S, et al. Does monocyte/high-density lipoprotein cholesterol ratio predict saphenous vein graft patency in patients with stable angina pectoris? Koşuyolu Heart J 2017 ; 20 : 7-12.
  • [37.] Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev 2003 ; 24 : 47-66.
  • [38.] Weglicki WB, Phillips TM, Mak IT, et al. Cytokines, neuropeptides, and reperfusion injury during magnesium deficiency. Ann N Y Acad Sci 1994 ; 723 : 246-57.
  • [39.] Kabashima H, Nagata K, Maeda K, Iijima T. Involvement of substance P, mast cells, TNF-α and ICAM-1 in the infiltration of inflammatory cells in human periapical granulomas. J Oral Pathol Med 2002 ; 31 : 175-80.
  • [40.] Ferre S, Baldoli E, Leidi M, Maier JA. Magnesium deficiency promotes a pro-atherogenic phenotype in cultured human endothelial cells via activation of NF-κB. Biochim Biophys Acta 2010 ; 1802 : 952-8.
  • [41.] Barbagallo M, Dominguez LJ, Galioto A, Pineo A, Belvedere M. Oral magnesium supplementation improves vascular function in elderly diabetic patients. Magnes Res 2010 ; 23 : 131-7.
  • [42.] King DE, Mainous III AG, Geesey M, Egan BM, Rehman S. Magnesium supplement intake and C-reactive protein levels in adults. Nutr Res 2006 ; 26 : 193-6.
  • [43.] Song Y, Li TY, van Dam RM, Manson JE, Hu FB. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr 2007 ; 85 : 1068-74.